Back
ENGIE Brasil Energia SA Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
54
EGIEY
ENGIE Brasil Energia SA
Last Price:
$6.78
Seasonality Move:
3.64%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
Buy
54
ENGIE Brasil Energia SA (EGIEY)
is a Buy
Is ENGIE Brasil Energia SA a Buy, Sell or Hold?
-
The current ENGIE Brasil Energia SA [EGIEY] share price is $7.14. The Score for EGIEY is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
EGIEY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $271.02. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EGIEY Stock Price Chart
What is ENGIE Brasil Energia SA's stock price today?
-
The ENGIE Brasil Energia SA share price today is $7.14Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EGIEY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $271.02The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
EGIEY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.83 | Buy |
Relative Strength Index (14 RSI): | 65.17 | Buy |
Chaikin Money Flow: | 6147 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.41 - 6.87) | Buy |
Bollinger Bands (100): | (6.01 - 6.79) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.53 | Buy |
Relative Strength Index (14 RSI): | 57.28 | Buy |
Chaikin Money Flow: | 106003 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.42 - 267) | Buy |
Bollinger Bands (100): | (240.58 - 270.64) | Buy |
EGIEY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.91 | Buy |
20-day SMA: | 6.67 | Buy |
50-day SMA: | 6.45 | Buy |
200-day SMA: | 7.2 | Sell |
8-day EMA: | 5.4 | Buy |
20-day EMA: | 3.13 | Buy |
50-day EMA: | 1.48 | Buy |
200-day EMA: | 0.4 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 268.31 | Buy |
20-day SMA: | 253.84 | Buy |
50-day SMA: | 259.68 | Buy |
200-day SMA: | 253.36 | Buy |
8-day EMA: | 268.69 | Buy |
20-day EMA: | 260.57 | Buy |
50-day EMA: | 257.45 | Buy |
200-day EMA: | 244.33 | Buy |
ENGIE Brasil Energia SA Earnings Growth & EGIEY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
ENGIE Brasil Energia SA Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |